92 related articles for article (PubMed ID: 20564216)
1. Poly (ADP-ribose) polymerase-1 binds to BCL2 major breakpoint region and regulates BCL2 expression.
Yang N; Gong F; Sun L; Yang D; Han X; Ma C; Sun Y
J Cell Biochem; 2010 Aug; 110(5):1208-18. PubMed ID: 20564216
[TBL] [Abstract][Full Text] [Related]
2. The BCL2 major breakpoint region (mbr) regulates gene expression.
Ma C; Zhang J; Durrin LK; Lv J; Zhu D; Han X; Sun Y
Oncogene; 2007 Apr; 26(18):2649-57. PubMed ID: 17057736
[TBL] [Abstract][Full Text] [Related]
3. The bcl-2 major breakpoint region (mbr) possesses transcriptional regulatory function.
Zhang J; Ma C; Han X; Durrin LK; Sun Y
Gene; 2006 Sep; 379():127-31. PubMed ID: 16777355
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the expression or recruitment of components of the DNA synthesome by poly(ADP-ribose) polymerase.
Simbulan-Rosenthal CM; Rosenthal DS; Boulares AH; Hickey RJ; Malkas LH; Coll JM; Smulson ME
Biochemistry; 1998 Jun; 37(26):9363-70. PubMed ID: 9649317
[TBL] [Abstract][Full Text] [Related]
5. Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.
Vaandrager JW; Schuuring E; Raap T; Philippo K; Kleiverda K; Kluin P
Genes Chromosomes Cancer; 2000 Jan; 27(1):85-94. PubMed ID: 10564590
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells.
Sun SY; Yue P; Zhou JY; Wang Y; Choi Kim HR; Lotan R; Wu GS
Biochem Biophys Res Commun; 2001 Jan; 280(3):788-97. PubMed ID: 11162590
[TBL] [Abstract][Full Text] [Related]
7. The effect of 3-aminobenzamide, inhibitor of poly(ADP-ribose) polymerase, on human osteosarcoma cells.
De Blasio A; Musmeci MT; Giuliano M; Lauricella M; Emanuele S; D'Anneo A; Vassallo B; Tesoriere G; Vento R
Int J Oncol; 2003 Dec; 23(6):1521-8. PubMed ID: 14612922
[TBL] [Abstract][Full Text] [Related]
8. Protein expression and intracellular localization of prostate apoptosis response-4 (Par-4) are associated with apoptosis induction in nasopharyngeal carcinoma cell lines.
Lee JW; Lee KF; Hsu HY; Hsu LP; Shih WL; Chu YC; Hsiao WT; Liu PF
Cancer Lett; 2007 Nov; 257(2):252-62. PubMed ID: 17881119
[TBL] [Abstract][Full Text] [Related]
9. Expression and replication timing patterns of wildtype and translocated BCL2 genes.
Sun Y; Wyatt RT; Bigley A; Krontiris TG
Genomics; 2001 Apr; 73(2):161-70. PubMed ID: 11318606
[TBL] [Abstract][Full Text] [Related]
10. Pseudonegative BCL2 protein expression in a t(14;18) translocation positive lymphoma cell line: a need for an alternative BCL2 antibody.
Masir N; Campbell LJ; Jones M; Mason DY
Pathology; 2010 Apr; 42(3):212-6. PubMed ID: 20350212
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
Ibrado AM; Huang Y; Fang G; Liu L; Bhalla K
Cancer Res; 1996 Oct; 56(20):4743-8. PubMed ID: 8840993
[TBL] [Abstract][Full Text] [Related]
12. BCL2 complex rearrangement in follicular lymphoma: translocation mbr/JH and deletion in the vcr region of the same BCL2 allele.
Séité P; Hillion J; d'Agay MF; Berger R; Larsen CJ
Oncogene; 1993 Nov; 8(11):3073-80. PubMed ID: 8414508
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
Kuo ML; Shen SC; Yang CH; Chuang SE; Cheng AL; Huang TS
Oncogene; 1998 Oct; 17(17):2225-34. PubMed ID: 9811453
[TBL] [Abstract][Full Text] [Related]
14. BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemia.
Kornblau SM; Vu HT; Ruvolo P; Estrov Z; O'Brien S; Cortes J; Kantarjian H; Andreeff M; May WS
Clin Cancer Res; 2000 Apr; 6(4):1401-9. PubMed ID: 10778970
[TBL] [Abstract][Full Text] [Related]
15. The expression of poly(ADP-ribose) polymerase during differentiation-linked DNA replication reveals that it is a component of the multiprotein DNA replication complex.
Simbulan-Rosenthal CM; Rosenthal DS; Hilz H; Hickey R; Malkas L; Applegren N; Wu Y; Bers G; Smulson ME
Biochemistry; 1996 Sep; 35(36):11622-33. PubMed ID: 8794742
[TBL] [Abstract][Full Text] [Related]
16. In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation.
Boehrer S; Chow KU; Beske F; Kukoc-Zivojnov N; Puccetti E; Ruthardt M; Baum C; Rangnekar VM; Hoelzer D; Mitrou PS; Weidmann E
Cancer Res; 2002 Mar; 62(6):1768-75. PubMed ID: 11912153
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of JP-8 jet fuel toxicity. I. Induction of apoptosis in rat lung epithelial cells.
Stoica BA; Boulares AH; Rosenthal DS; Iyer S; Hamilton ID; Smulson ME
Toxicol Appl Pharmacol; 2001 Mar; 171(2):94-106. PubMed ID: 11222085
[TBL] [Abstract][Full Text] [Related]
18. DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cells.
Singh S; Chhipa RR; Vijayakumar MV; Bhat MK
Cancer Lett; 2006 May; 236(2):213-21. PubMed ID: 15996812
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor.
Soldatenkov VA; Albor A; Patel BK; Dreszer R; Dritschilo A; Notario V
Oncogene; 1999 Jul; 18(27):3954-62. PubMed ID: 10435618
[TBL] [Abstract][Full Text] [Related]
20. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
